This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Sep;13(9):860-2.

doi: 10.1016/S1470-2045(12)70382-0.

Childhood Philadelphia-chromosome-positive B-lymphoblastic leukaemia

Deborah Thomas¹

Affiliations

PMID: 22935232
DOI: 10.1016/S1470-2045(12)70382-0

Comment

Childhood Philadelphia-chromosome-positive B-lymphoblastic leukaemia

Deborah Thomas. Lancet Oncol. 2012 Sep.

. 2012 Sep;13(9):860-2.

doi: 10.1016/S1470-2045(12)70382-0.

Author

Deborah Thomas¹

Affiliation

¹ Department of Leukemia, University of Texas MD Anderson Cancer Center, Unit 428, Houston, TX 77030, USA. debthomas@mdanderson.org

PMID: 22935232
DOI: 10.1016/S1470-2045(12)70382-0

No abstract available

PubMed Disclaimer

Comment on

Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study.
Biondi A, Schrappe M, De Lorenzo P, Castor A, Lucchini G, Gandemer V, Pieters R, Stary J, Escherich G, Campbell M, Li CK, Vora A, Aricò M, Röttgers S, Saha V, Valsecchi MG. Biondi A, et al. Lancet Oncol. 2012 Sep;13(9):936-45. doi: 10.1016/S1470-2045(12)70377-7. Epub 2012 Aug 14. Lancet Oncol. 2012. PMID: 22898679 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science